Skip to main content

Table 1 Patient characteristics by surgical approach

From: Single-port thoracoscopic anatomic resection for chronic inflammatory lung disease

  SP-VATS
(n = 65)
MP-VATS
(n = 105)
P-value
Age, mean ± SD 54.2 ± 12.6 52.4 ± 12.5 0.351
Sex, male (%) 33 (50.8) 56 (53.3) 0.745
Etiology, n (%)    0.325
 Bronchiectasis 31 (47.7) 42 (40.0)  
 TB/NTM infection 34 (52.3) 63 (60.0)  
Comorbidity, n (%)    
 Hypertension 12 (18.5) 18 (17.1) 0.827
 Diabetes mellitus 12 (18.5) 34 (32.4) 0.047
 Coronary artery disease 1 (1.5) 3 (2.9) 1.000
 GERD 0 3 (2.9) 0.287
 CKD/ESRD 1 (1.5) 3 (2.9) 1.000
 Liver cirrhosis 1 (1.5) 3 (2.9) 1.000
 Malignancy history 3 (4.6) 2 (1.9) 0.372
Pulmonary function test, mean ± SD    
 FEV1 (L) 2.16 ± 0.84 2.27 ± 0.80 0.458
 PEF1/FVC (%) 76.9 ± 11.0 77.5 ± 10.3 0.755
Surgical indication, n (%)    0.066
 Hemoptysis 36 (55.4) 48 (45.7)  
 Recurrent pneumonia 11 (16.9) 16 (15.2)  
 Cavity, infected 11 (16.9) 13 (12.4)  
 Destroyed lobe 2 (3.1) 4 (3.8)  
 TB medication failure 3 (4.6) 23 (21.9)  
 Undetermined mass 2 (3.1) 1 (1.0)  
Sidedness, n (%)    0.281
 Right 35 (53.8) 55 (52.4)  
 Left 27 (41.5) 49 (46.7)  
 Bilateral 3 (4.6) 2 (1.0)  
Extent of resection, n (%)    0.435
 Upper lobe 32 (49.2) 63 (60.0)  
 Middle lobe 9 (13.8) 16 (15.2)  
 Lower lobe 15 (23.1) 20 (19.0)  
 Upper + middle lobe 3 (4.6) 2 (1.9)  
 Upper + lower lobe 3 (4.6) 3 (2.9)  
 Middle + lower lobe 3 (4.6) 1 (1.0)  
Surgical procedure, n (%)    0.226
 Lobectomy 27 (41.5) 52 (49.5)  
 Segmentectomy 28 (43.1) 47 (44.8)  
 Lob. + Seg., ipsilateral 6 (9.2) 4 (3.8)  
 Lob. + Seg., bilateral 1 (1.5) 1 (1.0)  
 Seg. + Seg., ipsilateral 0 1 (1.0)  
 Seg. + Seg., bilateral 2 (3.1) 0  
 Bilobectomy 1 (1.5) 0  
  1. CKD/ESRD chronic kidney disease/end-stage renal disease, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, GERD gastroesophageal reflux disease, Lob. Lobectomy, NTM nontuberculous mycobacteria, SD standard deviation, Seg. Segmentectomy, TB tuberculosis